Genetic Susceptibility to Breast and Ovarian Cancer
Publisher: American College of Medical Genetics 1999
Number of pages: 236
The Guidelines have been prepared to help the primary care provider to participate in the pre- and post-test education and counseling required for every patient contemplating genetic testing for breast and ovarian cancer. Although some important genetic, epidemiological, and clinical issues remain unresolved, it is essential that all health care providers understand the familial basis of some cancers and the potential applications of genetic testing as part of the risk assessment process.
Home page url
Download or read it online for free here:
by F.C. Fernandes, L.M. Brasil, R. da Veiga (eds.) - InTech
Mammography remains at the backbone of medical tools to examine the human breast. The early detection of breast cancer typically uses adjunct tests to mammogram such as ultrasound, positron emission mammography, electrical impedance, and others.
- World Health Organization
This publication gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. It outlines the complementary strategies, and highlights the need for collaboration across programmes, organizations and partners.
- International Agency for Research on Cancer
This volume provides an assessment of the carcinogenicity of 14 drugs and herbal products. The authors relied on epidemiological studies to evaluate the carcinogenic hazard to humans exposed to the drugs digoxin, pioglitazone and hydrochlorothiazide.
by S. Nass, H. Moses - National Academies Press
Many cancer patients are diagnosed at a stage in which the cancer is too far advanced to be cured. There is tremendous opportunity to improve the outcome for people with cancer by enhancing detection and treatment approaches.